Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes

Multiple Sclerosis

Volumn 21, Issue 13, 2015, Pages 1626-1628

  Louapre, Céline ^a   Lubetzki, Catherine ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Multiple sclerosis; neurodegeneration; neuroinflammation; neuroprotection

Indexed keywords

N ACETYLASPARTIC ACID;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID BRAIN LEVEL; BRAIN ATROPHY; DEMYELINATION; DISABILITY; GRAY MATTER; HUMAN; MOLECULAR DIAGNOSIS; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; POSITRON EMISSION TOMOGRAPHY; SHORT SURVEY; WHITE MATTER INJURY; BRAIN; BRAIN TUMOR; DEMYELINATING DISEASE; ENCEPHALITIS; FEMALE; HEMIANOPIA; PATHOLOGY;

BRAIN; BRAIN NEOPLASMS; DEMYELINATING DISEASES; ENCEPHALITIS; FEMALE; HEMIANOPSIA; HUMANS;

EID: 84986215724     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515587598     Document Type: Short Survey

References (19)

1. Scalfari A, Neuhaus A, Daumer M, et al. Onset of secondary progressive phase and long-term evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry 2014; 85: 67-75.
2. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712.
3. Peterson JW, Bö L, Mörk S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400.
4. Magliozzi R, Howell OW, Reeves C, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010; 68: 477-493.
5. Kipp M, Wagenknecht N, Beyer C, et al. Thalamus pathology in multiple sclerosis: From biology to clinical application. Cell Mol Life Sci 2015; 72: 1127-1147.
6. Geurts JJ, Bö L, Roosendaal SD, et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007; 66: 819-827.
7. Lucchinetti CF, Popescu BF, Bunyan RF, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011; 365: 2188-2197.
8. Wylezinska M, Cifelli A, Jezzard P, et al. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 2003; 60: 1949-1954.
9. Steenwijk MD, Daams M, Pouwels PJ, et al. What explains gray matter atrophy in long-standing multiple sclerosis? Radiology 2014; 272: 832-842.
10. Stromillo ML, Giorgio A, Rossi F, et al. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. Neurology 2013; 80: 2090-2094.
11. Freeman L, Garcia-Lorenzo D, Bottin L, et al. Evidence of widespread cortical neuronal damage in patients with multiple sclerosis: A surface-based study using PET with [11C]-flumazenil. Mult Scler 2013; 19 Suppl. (abstract 205).
12. Mainero C, Louapre C, Govindarajan ST, et al. A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain 2015; 138: 932-945.
13. Baranzini SE, Srinivasan R, Khankhanian P, et al. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain 2010; 133: 2603-2611.
14. Kalincik T, Vivek V, Jokubaitis V, et al. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain 2013; 136: 3609-3617.
15. Schoonheim MM, Popescu V, Rueda Lopes FC, et al. Subcortical atrophy and cognition: Sex effects in multiple sclerosis. Neurology 2012; 79: 1754-1761.
16. Du S, Itoh N, Askarinam S, et al. XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2014; 111: 2806-2811.
17. Friese MA, Schattling B, Fugger L,. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 2014; 10: 225-238.
18. Fünfschilling U, Supplie LM, Mahad D, et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012; 485: 517-521.
19. Campbell GR, Ziabreva I, Reeve AK, et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 2011; 69: 481-492.